Warning! GuruFocus detected
1 Severe warning sign
with THAR.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Tharimmune Inc
NAICS : 325412
SIC : 2834
ISIN : US4327052001
Description
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset, known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.58 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -13.9 | |||||
| 3-Year EPS without NRI Growth Rate | -14.7 | |||||
| 3-Year FCF Growth Rate | -32.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 88.98 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 58.76 | |||||
| 9-Day RSI | 51.28 | |||||
| 14-Day RSI | 46.42 | |||||
| 3-1 Month Momentum % | -20.66 | |||||
| 6-1 Month Momentum % | -37.98 | |||||
| 12-1 Month Momentum % | -74.09 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.35 | |||||
| Quick Ratio | 2.35 | |||||
| Cash Ratio | 2.14 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -196.6 | |||||
| Shareholder Yield % | -345.86 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -196.23 | |||||
| ROA % | -148.61 | |||||
| ROIC % | -6539.41 | |||||
| ROCE % | -195.99 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.62 | |||||
| Price-to-Tangible-Book | 0.62 | |||||
| EV-to-FCF | 0.01 | |||||
| Price-to-Net-Current-Asset-Value | 0.62 | |||||
| Price-to-Net-Cash | 0.74 | |||||
| FCF Yield % | -328.49 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:THAR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Tharimmune Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -10.881 | ||
| Beta | 1.14 | ||
| 3-Year Sharpe Ratio | -0.83 | ||
| 3-Year Sortino Ratio | -1.46 | ||
| Volatility % | 48.83 | ||
| 14-Day RSI | 46.42 | ||
| 14-Day ATR ($) | 0.12555 | ||
| 20-Day SMA ($) | 1.475675 | ||
| 12-1 Month Momentum % | -74.09 | ||
| 52-Week Range ($) | 1.28 - 7.460999 | ||
| Shares Outstanding (Mil) | 1.93 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Tharimmune Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Tharimmune Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Tharimmune Inc Frequently Asked Questions
What is Tharimmune Inc(THAR)'s stock price today?
The current price of THAR is $1.46. The 52 week high of THAR is $7.46 and 52 week low is $1.28.
When is next earnings date of Tharimmune Inc(THAR)?
The next earnings date of Tharimmune Inc(THAR) is 2025-05-09 Est..
Does Tharimmune Inc(THAR) pay dividends? If so, how much?
Tharimmune Inc(THAR) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers